Sidewinder Therapeutics
Sidewinder Therapeutics
Sidewinder Therapeutics
Pioneering next-generation bispecific ADCs for cancer treatment.
About
Sidewinder Therapeutics is pioneering the next generation of bispecific antibody-drug conjugates (ADCs) designed to expand the therapeutic window for patients with difficult-to-treat cancers. Their engineered ADCs target receptor co-complexes highly expressed on solid tumors, aiming for enhanced tumor cell specificity and internalization. The company is built by a team of entrepreneurs, scientists, and drug developers committed to delivering these advanced therapies. Teams look it up for Biotechnology, Pharmaceuticals, Oncology.
What does Sidewinder Therapeutics do?
Sidewinder Therapeutics is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Oncology, Drug Discovery. It is based in San Diego, California, USA and was founded in 2026. Public records show about 9 people and $137M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Sidewinder Therapeutics raised?
Sidewinder Therapeutics has raised a total of $137M in funding. The most recent round on record is Series B.
Where is Sidewinder Therapeutics headquartered?
Sidewinder Therapeutics is headquartered in San Diego, California, USA.
When was Sidewinder Therapeutics founded?
Sidewinder Therapeutics was founded in 2026.
What industry does Sidewinder Therapeutics operate in?
Sidewinder Therapeutics operates in Biotechnology, Pharmaceuticals, Oncology, Drug Discovery.
How many employees does Sidewinder Therapeutics have?
Sidewinder Therapeutics has approximately 9 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
